The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 09, 2014

Filed:

Aug. 02, 2012
Applicants:

Jeffery W. Kelly, LaJolla, CA (US);

Joshua L. Price, Vineyard, UT (US);

Elizabeth K. Culyba, Arlington, MA (US);

Evan T. Powers, San Diego, CA (US);

Inventors:

Jeffery W. Kelly, LaJolla, CA (US);

Joshua L. Price, Vineyard, UT (US);

Elizabeth K. Culyba, Arlington, MA (US);

Evan T. Powers, San Diego, CA (US);

Assignee:

The Scripps Research Institute, LaJolla, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 5/07 (2010.01); C07K 1/00 (2006.01); C07K 16/00 (2006.01); C07K 14/00 (2006.01); C07K 1/107 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/00 (2013.01); C07K 2319/70 (2013.01); C07K 16/00 (2013.01); A61K 38/00 (2013.01); C07K 1/1077 (2013.01);
Abstract

A chimeric therapeutic polypeptide of a pre-existing therapeutic polypeptide is disclosed, as are a method of enhancing folded stabilization and a pharmaceutical composition of the glycosylated chimer. The pre-existing and chimeric polypeptides have substantially the same length, substantially the same amino acid residue sequence, and exhibit at least one tight turn containing a sequence of four to about seven amino acid residues in which at least two amino acid side chains extend on the same side of the tight turn and are within less than about 7 Å of each other. The chimeric therapeutic polypeptide has the sequon Aro-(Xxx)n-(Zzz)p-Asn-Yyy-Thr/Ser (SEQ ID NO:001) within that tight turn sequence such that the side chains of the Aro, Asn and Thr/Ser amino acid residues project on the same side of the turn and are within less than about 7 Å of each other. That sequon is absent from the pre-existing therapeutic polypeptide.


Find Patent Forward Citations

Loading…